About Us - Leading the development of pharmaceutical generics with growing strengths in focused therapeutic segments.

Overview

Driven by its vision of becoming a leading global generics organization, Glenmark Generics Ltd. (GGL) has structured its businesses as US Generics, European Generics, the Active Pharmaceutical Ingredient (API) business and the Oncology Business. A subsidiary of Glenmark Pharmaceuticals Limited, GGL focuses on developing, manufacturing, selling and the distribution of generics through wholesalers, retailers and pharmacy chains. From APIs to front end marketing capabilities, GGL's businesses are vertically integrated into the generics market, by focusing on key niche segments including Dermatology, Hormones, Controlled Substances, Oncology and Modified Release Products.